Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)
NCT02466035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-03-22
Summary
Lactobacillus GG (LGG) is able to exert long lasting effects in children with atopic disorders. Nutramigen LGG accelerates tolerance acquisition in infants with cow's milk allergy. The mechanisms of these effects are still largely undefined. The effect of LGG could be related at least in part by the immunoregulatory role played by LGG. This probiotic can balance the generation of cytokines possibly involved in IgE- or non-IgE-mediated cow's milk allergy Interleulkin (IL)-4, IL-5, IL-10, IFN-γ , TGF-β, and TNF-Υ), which can contribute to modulation of inflammatory processes. The investigators have demonstrated that children with IgE-mediated CMA produce significantly higher level of IL-4 and IL-13 in response to cow's milk protein, and that tolerance is associated with a marked reduction of IL-13 production and a concomitant increased frequency of IFN-γ releasing cells.
Epigenetics studies the heritable (and potentially reversible) changes of the genome inherited from one cell generation to the next which alter gene expression but do not involve changes in primary DNA sequences, highlighting the complexity of the inter-relationship between genetics and nutrition. There are three distinct, but closely interacting, epigenetic mechanisms (histone acetylation, DNA methylation, and non-coding microRNAs) that are responsible for modifying the expression of critical genes associated with physiologic and pathologic processes. The profile of epigenetic modifications associated with Th lineage commitment, coupled with the sensitivity of the early developmental period, has led to speculation that factors that disrupt these pathways may increase the risk of allergic diseases. Specifically, effects on DNA methylation and endogenous histone deacetylase inhibitors acting on specific pathways (Th1 and T regulatory cell differentiation) may favour Th2-associated allergic differentiation. MicroRNAs are another structural components of an epigenetic mechanism of post-transcriptional regulation of messenger RNA translation. It has been recently identified a specific Th2-associated microRNA (miR-21) that is critical for the regulation of Th cell polarization. It has been previously demonstrated an inverse DNA methylation pattern of cytokines involved in Th2 response (IL-4, IL-5) compared with cytokines involved in Th1 response (IL-10, INF- y) in children with CMA acquiring oral tolerance, with the most pronounced effects in those treated with Nutramigen LGG. The current study will prospectively evaluate the effect of Nutramigen LGG and other commercially available hypoallergenic formulas on epigenetic mechanisms that may be related to tolerance acquisition.
Conditions
- Cow's Milk Allergy
Interventions
- DIETARY_SUPPLEMENT
-
Extensively hydrolyzed casein formula plus Lactobacillus rhamnosus GG
Extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG
Sponsors & Collaborators
-
Federico II University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Epigenetic Features of FoxP3 in Children With Cow's Milk Allergy
NCT02779881 ·Status: COMPLETED
-
Hypoallergenicity of a New Formula in Subjects With Cow's Milk Allergy
NCT06134466 ·Status: COMPLETED ·Phase: NA
-
Impact of Infant Formula on Resolution of Cow's Milk Allergy
NCT02719405 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy
NCT01634490 ·Status: COMPLETED
-
Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants
NCT02077088 ·Status: COMPLETED ·Phase: NA
-
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy
NCT02379598 ·Status: COMPLETED
-
A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy
NCT00664768 ·Status: COMPLETED ·Phase: NA
-
Hypoallergenicity To Substitutive Formulas In Children With Cow's Milk Allergy
NCT02144428 ·Status: UNKNOWN
-
Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy
NCT06633289 ·Status: COMPLETED ·Phase: NA
-
Probiotics and Early Microbial Contact in Preterm Neonates
NCT01454661 ·Status: UNKNOWN ·Phase: NA
-
Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying
NCT01956682 ·Status: COMPLETED ·Phase: PHASE4
-
Infant Formula in Infants and Children With Cow's Milk Allergy
NCT06456541 ·Status: RECRUITING ·Phase: NA
-
Milk Oral Immunotherapy in Children to Treat Food Allergy
NCT01162473 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins
NCT03557671 ·Status: COMPLETED ·Phase: NA
-
Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy?
NCT01542970 ·Status: UNKNOWN ·Phase: NA
-
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
NCT01622426 ·Status: COMPLETED ·Phase: NA
-
Free Amino Acid-based Formula to Treat Children Cow's Milk Protein Allergy
NCT02536482 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
NCT01603368 ·Status: COMPLETED ·Phase: PHASE2
-
Growth and Safety of a Low Lactose Milk-Based Infant Formula
NCT01497314 ·Status: COMPLETED ·Phase: NA
-
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.
NCT06633250 ·Status: RECRUITING ·Phase: NA
-
Prebiotics in Prevention of Atopy
NCT02116452 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula
NCT02711163 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy
NCT07197814 ·Status: RECRUITING ·Phase: NA
-
Efficacy of the "Milk Ladder" Intervention in the Development of Tolerance and the Recognition of B Cell Epitopes in Babies Who Are Allergic to Cow's Milk Proteins
NCT03466931 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides, Beta-palmitate and Acidified Milk
NCT01197365 ·Status: COMPLETED ·Phase: NA